Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 1 |
2012 | 1 |
2014 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
[Tolvaptan, a vasopressin V2 receptor antagonist, is the world's first approved drug for treatment of autosomal dominant polycystic kidney disease (ADPKD)].
Nihon Yakurigaku Zasshi. 2022;157(4):254-260. doi: 10.1254/fpj.22006.
Nihon Yakurigaku Zasshi. 2022.
PMID: 35781456
Japanese.
Anti-edematous effects of tolvaptan in experimental rodent models.
Miyazaki T, Sakamoto Y, Yamashita T, Ohmoto K, Fujiki H.
Miyazaki T, et al. Among authors: ohmoto k.
Cardiovasc Drugs Ther. 2011 Dec;25 Suppl 1:S77-82. doi: 10.1007/s10557-011-6355-z.
Cardiovasc Drugs Ther. 2011.
PMID: 22120096
Item in Clipboard
Genetic screening for regulators of Prz1, a transcriptional factor acting downstream of calcineurin in fission yeast.
Koike A, Kato T, Sugiura R, Ma Y, Tabata Y, Ohmoto K, Sio SO, Kuno T.
Koike A, et al. Among authors: ohmoto k.
J Biol Chem. 2012 Jun 1;287(23):19294-303. doi: 10.1074/jbc.M111.310615. Epub 2012 Apr 11.
J Biol Chem. 2012.
PMID: 22496451
Free PMC article.
Item in Clipboard
Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury.
Aihara M, Fujiki H, Mizuguchi H, Hattori K, Ohmoto K, Ishikawa M, Nagano K, Yamamura Y.
Aihara M, et al. Among authors: ohmoto k.
J Pharmacol Exp Ther. 2014 May;349(2):258-67. doi: 10.1124/jpet.114.213256. Epub 2014 Feb 25.
J Pharmacol Exp Ther. 2014.
PMID: 24570071
Item in Clipboard
Chronic hyponatremia impairs memory in rats: effects of vasopressin antagonist tolvaptan.
Miyazaki T, Ohmoto K, Hirose T, Fujiki H.
Miyazaki T, et al. Among authors: ohmoto k.
J Endocrinol. 2010 Jul;206(1):105-11. doi: 10.1677/JOE-10-0050. Epub 2010 Apr 14.
J Endocrinol. 2010.
PMID: 20392812
Item in Clipboard
Cite
Cite